Therapeutic outcomes and prognostic factors in unresectable gallbladder cancer treated with gemcitabine plus cisplatin

Therapeutic outcomes and prognostic factors in unresectable gallbladder cancer treated with gemcitabine plus cisplatin

Abstract Background Gallbladder cancer (GBC) is likely to be diagnosed at progressive stages and shows a very poor prognosis. Combination therapy with gemcitabine and cisplatin (GEMCIS) has been widely used as first-line palliative chemotherapy for advanced GBC. This study was designed to investigat...

Full description

Bibliographic Details
Main Authors: Min su You, Ji Kon Ryu, Young Hoon Choi, Jin Ho Choi, Gunn Huh, Woo Hyun Paik, Sang Hyub Lee, Yong-Tae Kim
Format: Article
Language:English
Published: BMC 2019-01-01
Series:BMC Cancer
Subjects:
Gallbladder neoplasms
Gemcitabine
Cisplatin
Prognosis
Treatment outcome
Online Access:http://link.springer.com/article/10.1186/s12885-018-5211-y

Internet

http://link.springer.com/article/10.1186/s12885-018-5211-y

Similar Items